Peter E. Lobie
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- Growth Hormone and Insulin-like Growth Factors
Papers in
-
- Growth Hormone and Insulin-like Growth Factors 70
-
- Cancer, Hypoxia, and Metabolism 25
- Cancer-related molecular mechanisms research 21
- MicroRNA in disease regulation 17
- Co-authors
- Tao ZhuVijay PandeyHichem C. MertaniJo K. PerryKok‐Onn LeeGunnar NorstedtMichael J. WatersEyleen L. K. Goh
- Journals
- Journal of Biological Chemistry (26 papers)Endocrinology (24 papers)Cancer Research (8 papers)Oncogene (8 papers)Oncotarget (8 papers)
- Partner nations
- ChinaSingaporeNew Zealand
In The Last Decade
Peter E. Lobie
230 papers receiving 9.3k citations
Peers
Comparison fields: 5 of 137
- Cancer Research 2.8k
- Endocrinology, Diabetes and Metabolism 2.7k
- Oncology 2.4k
- Molecular Biology 5.2k
- Immunology 952
Countries citing papers authored by Peter E. Lobie
This map shows the geographic impact of Peter E. Lobie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Lobie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Lobie more than expected).
Fields of papers citing papers by Peter E. Lobie
This network shows the impact of papers produced by Peter E. Lobie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Lobie. The network helps show where Peter E. Lobie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter E. Lobie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 36 | |
| 5 | 2024 | 4 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 107 | |
| 10 | 2022 | 11 | |
| 11 | 2021 | 2 | |
| 12 | 2020 | 21 | |
| 13 | 2019 | 23 | |
| 14 | 2018 | 25 | |
| 15 | 2013 | 4 | |
| 16 | 2012 | 79 | |
| 17 | 2011 | 125 | |
| 18 | 2010 | 30 | |
| 19 | 2010 | 26 | |
| 20 | 1996 | 15 |
About Peter E. Lobie
Peter E. Lobie is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research, Oncology, Molecular Biology and Toxicology, having authored 233 papers that have together received 9.4k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (70 papers), Cytokine Signaling Pathways and Interactions (32 papers), Cancer, Hypoxia, and Metabolism (25 papers), Cancer Cells and Metastasis (21 papers), Cancer-related molecular mechanisms research (21 papers), MicroRNA in disease regulation (17 papers), Cancer-related gene regulation (17 papers) and Synthesis and biological activity (16 papers). The work is most often cited by research in Cancer Research (2.8k citations), Endocrinology, Diabetes and Metabolism (2.7k citations), Oncology (2.4k citations), Molecular Biology (5.2k citations) and Immunology (952 citations). Peter E. Lobie has collaborated with scholars based in China, Singapore and New Zealand. Frequent co-authors include Tao Zhu, Vijay Pandey, Hichem C. Mertani, Jo K. Perry, Kok‐Onn Lee, Gunnar Norstedt, Michael J. Waters, Eyleen L. K. Goh, Murray D. Mitchell and Zhengsheng Wu. Their work appears in journals such as Journal of Biological Chemistry, Endocrinology, Cancer Research, Oncogene and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.